Ivabradine for systolic heart failure.

JAAPA

At the time this article was written, Courtney M. Meade was a student in the Presbyterian College School of Pharmacy in Clinton, S.C. Jennifer N. Clements is associate professor of pharmacy practice in the Presbyterian College School of Pharmacy. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Published: March 2018

Ivabradine works in the sinoatrial node to prolong diastolic depolarization and reduce heart rate. In patients with chronic systolic heart failure, this drug has reduced the risk of hospitalization when used in combination with other optimal pharmacotherapy.

Download full-text PDF	Source
http://dx.doi.org/10.1097/01.JAA.0000530305.69021.02	DOI Listing

Publication Analysis

Top Keywords

systolic heart

heart failure

ivabradine systolic

failure ivabradine

ivabradine works

works sinoatrial

sinoatrial node

node prolong

prolong diastolic

diastolic depolarization

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!